Phase III trials
Clinical Trials Watch
This section contains information about clinical trials that are:
- Currently recruiting participants
- Conducted at least in one European country
- In phase III (in these trials the drug / treatment is tested in large groups of people, involving from several hundred to several thousand participants. These trials are conducted to provide stronger evidence of the effectiveness and safety of the new drug / treatment.)
How many Phase III trials are reported in the CTW?
The CTW reports currently 8 ongoing Phase III clinical trials recruiting participants in Europe. These trials are listened in the table below:
| Study | Study sponsor | Name of the drug | Condition |
| CLARITY-AD | Eisai | BAN2401 | Early Alzheimer's disease |
| GAIN | Cortexyme | COR388 | Mild to moderate Alzheimer's disease dementia |
| GRADUATE 1 & GRADUATE 2 | Hoffmann- La Roche | Gantenerumab | Prodromal to mild Alzheimer’s disease |
| LO-MAPT | University Hospital, Toulouse | Omega-3 treatment | Subjective memory complaints of family history of Alzheimer's disease |
| LUCIDITY | TauRx Therapeutics Ltd | TRx0237 | Mild to moderate Alzheimer's disease |
| NorAD | Imperial College London | Guanfacine | Mild to moderate Alzheimer's disease |
| 17-AVP-786-305 | Avanir Pharmaceuticals | AVP-786 | Agitation in people with dementia of the Alzheimer's type |
Last Updated: Wednesday 03 June 2020
